Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors: Effective April 12, 2017

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

April 17, 2017

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the addition of Lisa Wipperman Heine to the Company’s Board of Directors, effective on April 12, 2017.

Surmodics notes that Ms. Wipperman Heine has spent over 25 years in leadership positions in the medical device industry. She is currently the Chief Operating Officer at Mitralign, an innovator in transcatheter tricuspid and mitral valve therapies. Prior to joining Mitralign, Wipperman Heine was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption.

Ms. Wipperman has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, Wipperman Heine helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Wipperman Heine received her M.S. degree from the University of Manitoba and her B.A. degree from St. Olaf College.

“We are pleased that Lisa Wipperman Heine will be joining our board,” said Gary Maharaj, President and Chief Executive Officer. “Lisa brings a broad range of experience in strategic roles and in developing devices for vascular repair, and we look forward to her contributions as we continue to work toward achieving our goal of improving the lives of patients. She joins Surmodics at an exciting time as we are preparing to deliver on many milestones including advancing our pipeline products in clinical trials.”

“I am honored to join a company that is focused on creating life changing products for patients,” said Lisa Wipperman Heine. “Surmodics continues to differentiate itself as a leader in the medical device sector with an evolving business model, and I look forward to providing additional insight as the company continues to grow and build out its business.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.